Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05554146 · ClinicalTrials.gov registry record · NA

Pain Inflammation and Cannabis in HIV

A NA study of HIV Infections and Neuropathic Pain, sponsored by Montefiore Medical Center.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT05554146 is a NA study of HIV Infections and Neuropathic Pain that has completed, run by Montefiore Medical Center. The registered enrollment target is 35 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05554146, a NA study of HIV Infections and Neuropathic Pain, has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

This study will examine how medical cannabis use affects neuropathic pain, inflammation and adverse events in people living with HIV (PLWH) with neuropathic pain. The investigators will observe how varying ratios of tetrahydrocannabinol (THC) and cannabidiol (CBD) in medical cannabis impact neuropathic pain, inflammation and adverse events.

Conditions Studied

HIV Infections Neuropathic Pain Cannabis

Interventions

  • OTHER Receipt of Coupon for Placebo Soft-Gel Capsule
  • OTHER Receipt of Coupon for High THC Soft-Gel Capsule
  • OTHER Receipt of Coupon for Equal THC and CBD Soft-Gel Capsule
  • OTHER Receipt of Coupon for High CBD Soft-Gel Capsule

Study Locations (1)

New York

  • Montefiore Health System - The Bronx

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2022-10-28
Est. Completion 2024-05-03
Phase NA

Sponsor

Montefiore Medical Center

345 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05554146

The ClinicalTrials.gov registry entry for NCT05554146 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (92% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 4 interventions - of which Receipt of Coupon for Placebo Soft-Gel Capsule is the first listed.

NCT05554146 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05554146 about?

NCT05554146 is a clinical study titled "Pain Inflammation and Cannabis in HIV". This study will examine how medical cannabis use affects neuropathic pain, inflammation and adverse events in people living with HIV (PLWH) with neuropathic pain. The investigators will observe how varying ratios of tetrahydrocannabinol (THC) and cannabidiol (CBD) in medical cannabis impact neuropat...

What is the current status of trial NCT05554146?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2022-10-28. Estimated completion is 2024-05-03.

What conditions does trial NCT05554146 study?

This clinical trial studies the following conditions: HIV Infections, Neuropathic Pain, Cannabis.

What interventions are being tested in trial NCT05554146?

The interventions under investigation include: Receipt of Coupon for Placebo Soft-Gel Capsule (OTHER), Receipt of Coupon for High THC Soft-Gel Capsule (OTHER), Receipt of Coupon for Equal THC and CBD Soft-Gel Capsule (OTHER), Receipt of Coupon for High CBD Soft-Gel Capsule (OTHER).

Who is sponsoring clinical trial NCT05554146?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05554146 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Neuropathic Pain

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.